273 related articles for article (PubMed ID: 9362205)
1. Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis.
Cervoni JP; Lecomte T; Cellier C; Auroux J; Simon C; Landi B; Gadano A; Barbier JP
Am J Gastroenterol; 1997 Nov; 92(11):2113-4. PubMed ID: 9362205
[TBL] [Abstract][Full Text] [Related]
2. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
[TBL] [Abstract][Full Text] [Related]
3. Terlipressin and albumin combination treatment in hepatorenal syndrome.
Danalioglu A; Cakaloglu Y; Karaca C; Aksoy N; Akyuz F; Ozdil S; Demir K; Besisik F; Boztas G; Mungan Z; Kaymakoglu S; Okten A
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccciii-cccv. PubMed ID: 15244209
[TBL] [Abstract][Full Text] [Related]
4. Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis.
Sigal SH; Sanyal AJ; Frederick RT; Weinberg EM; Pappas SC; Jamil K
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3455-3457.e3. PubMed ID: 36848979
[No Abstract] [Full Text] [Related]
5. Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients.
Dagher L; Patch D; Marley R; Moore K; Burroughs A
Aliment Pharmacol Ther; 2000 May; 14(5):515-21. PubMed ID: 10792112
[TBL] [Abstract][Full Text] [Related]
6. Terlipressin in hepatorenal syndrome.
Mazur JE; Cooper TB; Dasta JF
Ann Pharmacother; 2011 Mar; 45(3):380-7. PubMed ID: 21386023
[TBL] [Abstract][Full Text] [Related]
7. Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.
Alessandria C; Debernardi-Venon W; Carello M; Ceretto S; Rizzetto M; Marzano A
Dig Liver Dis; 2009 Apr; 41(4):298-302. PubMed ID: 19158001
[TBL] [Abstract][Full Text] [Related]
8. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
9. Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome.
Di Micoli A; Bracci E; Cappa FM; Casadio R; Zambruni A; Fontana K; Bernardi M; Trevisani F
Dig Liver Dis; 2008 Apr; 40(4):304-5. PubMed ID: 18160353
[TBL] [Abstract][Full Text] [Related]
10. Review article: pharmacological treatment of hepatorenal syndrome.
Ginès P; Torre A; Terra C; Guevara M
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():57-62; discussion 63-4. PubMed ID: 15335404
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient.
Ibrisim D; Cakaloglu Y; Akyuz F; Karadag A; Ozdil S; Besisik F; Mungan Z; Okten A
Scand J Gastroenterol; 2006 Jul; 41(7):862-5. PubMed ID: 16785202
[TBL] [Abstract][Full Text] [Related]
12. Terlipressin and gelafundin: safe therapy of hepatorenal syndrome.
Saner F; Kavuk I; Lang H; Biglarnia R; Frühauf NR; Schäfers RF; Malagó M; Broelsch CE
Eur J Med Res; 2004 Feb; 9(2):78-82. PubMed ID: 15090293
[TBL] [Abstract][Full Text] [Related]
13. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study.
Alessandria C; Ottobrelli A; Debernardi-Venon W; Todros L; Cerenzia MT; Martini S; Balzola F; Morgando A; Rizzetto M; Marzano A
J Hepatol; 2007 Oct; 47(4):499-505. PubMed ID: 17560680
[TBL] [Abstract][Full Text] [Related]
14. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
Sagi SV; Mittal S; Kasturi KS; Sood GK
J Gastroenterol Hepatol; 2010 May; 25(5):880-5. PubMed ID: 20074149
[TBL] [Abstract][Full Text] [Related]
15. Higher Respiratory Complications in Alcoholic Hepatitis Patients With Hepatorenal Syndrome When Treated With Terlipressin: Is it Safe?
Ariga KK; Verma G; Agrawal D
Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3197-3198. PubMed ID: 37031717
[No Abstract] [Full Text] [Related]
16. Terlipressin. Type I hepatorenal syndrome: an extra window of time before liver transplantation.
Prescrire Int; 2006 Dec; 15(86):220. PubMed ID: 17171813
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
Saner FH; Canbay A; Gerken G; Broelsch CE
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
[TBL] [Abstract][Full Text] [Related]
18. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
Ortega R; Ginès P; Uriz J; Cárdenas A; Calahorra B; De Las Heras D; Guevara M; Bataller R; Jiménez W; Arroyo V; Rodés J
Hepatology; 2002 Oct; 36(4 Pt 1):941-8. PubMed ID: 12297842
[TBL] [Abstract][Full Text] [Related]
19. Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?
Duhamel C; Mauillon J; Berkelmans I; Bourienne A; Tranvouez JL
Am J Gastroenterol; 2000 Oct; 95(10):2984-5. PubMed ID: 11051385
[No Abstract] [Full Text] [Related]
20. Hepatorenal syndrome: diagnosis and effect of terlipressin therapy in 4 pediatric patients.
Yousef N; Habes D; Ackermann O; Durand P; Bernard O; Jacquemin E
J Pediatr Gastroenterol Nutr; 2010 Jul; 51(1):100-2. PubMed ID: 20543721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
